| European Case Law Identifier: | ECLI:EP:BA:2018:T106315.20180412 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 12 April 2018 | ||||||||
| Case number: | T 1063/15 | ||||||||
| Application number: | 04781429.8 | ||||||||
| IPC class: | A61K 31/135 A61K 9/28 A61K 9/20 A61P 3/14 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | RAPID DISSOLUTION FORMULATION OF CINACALCET HCl | ||||||||
| Applicant name: | AMGEN INC. | ||||||||
| Opponent name: | Actavis Group PTC EHF RAFARM S.A. ZBM PATENTS, S.L. |
||||||||
| Board: | 3.3.07 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Extension of the scope of the claims Sufficiency of disclosure Inventive step |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t151063eu1.html
Date retrieved: 17 May 2021